COCRYSTAL PHARMA, INC., PRICES $8,000,000 COMMON STOCK OFFERING
May 01, 2018 08:30 ET
|
Cocrystal Pharma, Inc.
TUCKER, GA and BOTHELL, WA, May 01, 2018 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP), (“Cocrystal” or the “Company”) a clinical stage biotechnology company focused on developing...
Cocrystal Pharma Announces Uplist to The Nasdaq Capital Market
March 12, 2018 08:30 ET
|
Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, March 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and...